Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11300750 | 0.93 | NAAA (0.52) | ALDH1A1ATMTSHRHCAR2NAAA | |
| SCHEMBL11051780 | 0.91 | NAAA (0.55) | ALDH1A1TSHRHCAR2NAAAEPHX1 | |
| SCHEMBL25271914 | 0.91 | NAAA (0.55) | ALDH1A1TSHRHCAR2NAAAEPHX1 | |
| SCHEMBL25270381 | 0.91 | NAAA (0.55) | ALDH1A1TSHRHCAR2NAAAEPHX1 | |
| SCHEMBL14759112 | 0.91 | NAAA (0.55) | ALDH1A1TSHRHCAR2NAAAEPHX1 | |
| SCHEMBL16965707 | 0.91 | MEN1 (0.45) | ALDH1A1ATMTSHRHPGDMEN1 | |
| SCHEMBL27730146 | 0.88 | ALDH1A1 (0.47) | ALDH1A1ATMTSHRHPGDMEN1 | |
| SCHEMBL27437831 | 0.86 | ALDH1A1 (0.45) | ALDH1A1ATMTSHRHPGDMEN1 | |
| SCHEMBL8909513 | 0.86 | MEN1 (0.45) | ALDH1A1ATMTSHRMEN1KMT2A | |
| SCHEMBL15509316 | 0.86 | ALDH1A1 (0.41) | ALDH1A1ATMTSHRHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| US-20240158337-A1 | GAS-PHASE OXIDATIVE COUPLING OF ALCOHOLS AND AMINES USING HETEROGENEOUS CATALYSTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA | 2024-05-16 | — | — | US | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-20180072730-A1 | NOVEL 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION | HOFFMANN-LA ROCHE INC. (US) | 2018-03-15 | — | — | US | disclosed |
| EP-2568019-B1 | Inkjet ink | JNC CORP (JP) | 2015-09-02 | — | — | EP | disclosed |
| US-9040625-B2 | Water/oil repellent composition, method for its production and article | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-05-26 | — | — | US | disclosed |
| US-20140051797-A1 | WATER/OIL REPELLENT COMPOSITION, METHOD FOR ITS PRODUCTION AND ARTICLE | ASAHI GLASS COMPANY, LIMITED (JP) | 2014-02-20 | — | — | US | disclosed |
| EP-2568019-A1 | Inkjet ink | JNC Corporation (JP) | 2013-03-13 | — | — | EP | disclosed |
| US-8258148-B2 | Spiroindoline modulators of muscarinic receptors | VERTEX PHARMACEUTICAL INCORPORATED (US) | 2012-09-04 | — | — | US | disclosed |
| US-20100311720-A1 | Spiroindoline Modulators of Muscarinic Receptors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-12-09 | — | — | US | disclosed |
| CN-1224001-A | Process for preparation of carbonates and polycarbonates | MONSANTO CO (US) | 1999-07-28 | — | — | CN | disclosed |
| EP-0575191-B1 | Non-aqueous electrolyte solvent and battery containing this electrolyte | MITSUI PETROCHEMICAL IND (JP) | 1997-08-27 | — | — | EP | disclosed |
| US-5434290-A | Carbonylation of 1-cyanobut-2-ene with carbon monoxide and alkanol in presence of cobalt catalyst and activating organic carbonate solvent | BASF AKTIENGESELLSCHAFT (DE) | 1995-07-18 | — | — | US | disclosed |
| US-5385794-A | Lithium battery; carbamate and cyclic carbonate solvents | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1995-01-31 | — | — | US | disclosed |
| EP-0575191-A1 | Non-aqueous electrolyte solvent and battery containing this electrolyte | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1993-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311720-A1 | Spiroindoline Modulators of Muscarinic Receptors | CHRM3, CHRM2, CHRM4 | ALDH1A1 1076/4885ATM 1560/4885TSHR 79/4885 |
| US-20180072730-A1 | NOVEL 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION | TPMT, SULT1E1, UGT1A7 | ALDH1A1 235/4885ATM 4312/4885TSHR 4523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.